Disposition of asciminib, a potent BCR-ABL1 tyrosine kinase inhibitor, in healthy male subjects
Tran, Phi, Hanna, Imad, Eggimann, Fabian Kurt, Schoepfer, Joseph, Ray, Tapan, Zhu, Bing, Wang, Lai, Priess, Petra, Tian, Xianbin, Hourcade-Potelleret, Florence, Einolf, Heidi J.
Published in Xenobiotica (01.02.2020)
Published in Xenobiotica (01.02.2020)
Get full text
Journal Article
Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolam
Zhang, Hefei, Sheng, Jennifer, Ko, Jin H, Zheng, Cheng, Zhou, Wei, Priess, Petra, Lin, Wen, Novick, Steven
Published in Journal of clinical pharmacology (01.04.2015)
Published in Journal of clinical pharmacology (01.04.2015)
Get more information
Journal Article